Found 7 matching trials
A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
PHASE2This study will evaluate the effectiveness and safety of HRS-4642 in combin...
Location
Jiangsu Province Hospital
A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors
PHASE1To evaluate the safety and preliminary efficacy of HRS-4642 in combination ...
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
PHASE2To evaluate the safety and efficacy of HRS-4642 in Combination With AG for ...
Location
Ruijin Hospital Shanghai Jiaotong University School of Medicine
HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients
PHASE2This study is a single-arm phase II clinical study to include 32 patients w...
Location
First Affiliated Hospital of Zhejiang University Schlool of Medicine
HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
PHASE2This study is a Phase II clinical trial that plans to enroll 40 patients wi...
Location
First Affiliated Hospital of Zhejiang University Schlool of Medicine
HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
PHASE2To evaluate the safety and efficacy of HRS-4642 in Combination With AG and ...
Location
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer
PHASE3This study investigates the first-line treatment of advanced pancreatic can...
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine